GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
GSK Pharmaceuticals has published a mandatory notice under Section 124 of the Companies Act, 2013 regarding transfer of shares to the Investor Education and Protection Fund (IEPF). The company had already sent individual communications dated 27th May 2026 to shareholders who have not encashed dividend warrants for seven consecutive years (FY 2018-19). These shareholders are liable to have their shares transferred to IEPF. The notice includes details of affected shareholders uploaded on GSK's website. Affected shareholders can claim back their shares and accumulated dividends from IEPF by submitting Form IEPF-5 on the IEPF portal (www.iepf.gov.in). Contact details for the Registrar (KFin Technologies) and GSK's Share Department are provided.
This is a regulatory compliance filing with no direct impact on the company's financial health or stock price. Shareholders with unclaimed dividends from FY 2018-19 risk losing their shares if they don't claim them before the deadline.